| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biology and Molecular Biology Institute, San Diego State University San Diego, California 92182
Department of Basic and Department of Clinical Research La Jolla, California 92037
Department of Immunology, Department of Scripps Clinic and Research Foundation La Jolla, California 92037
Department of Medicine, New England Medical Center Hospitals Boston, Massachusettes 02111
Section of Endocrinology and Metabolism, Veterans Administration Medical Center Indianapolis, Indiana 46202
Address requests for reprints to: Dr. Constantine D. Tsoukas, Department of Biology and Molecular Biology Institute, San Diego State University, San Diego, California 92182.
The hormonal form of vitamin D, 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3], inhibits the proliferation of T lymphocytes and production of growth-promoting factors [including interleukin-2) (IL2) in CTLL2 murine cells. In this study, we investigated the role of monocytes in this hormone-mediated inhibitory effect, by testing the effects of 1,25-(OH)2D3 on the ability of the mitogenic lectin phytohemagglutinin (PHA) to induce T cell activation in either a monocyte-dependent or phorbol myristate acetate (PMA)-driven (monocyte-independent) system. The results indicate that proliferation of T cells and production of growth-promoting factors are inhibited by 1,25-(OH)2D3 only in the monocyte-dependent system.
Preincubation of monocytes with 1,25-(OH)2D3 for various periods of time and subsequent removal of the hormone resulted in inhibition of the PHA-driven proliferation of T cells. Preincubation for 2 h resulted in 20% inhibition, while preincubation for 36 h reduced proliferation to 50% of the control value [no 1,25-(OH)2D3 exposure].
These data suggested that monocytes are important participants in l,25-(OH)2D3-mediated events. Therefore, we tested the effects of the hormone on the production of IL1, a monocytederived product thought to be involved in the induction of IL2 release and the subsequent development of the T cell proliferative response. 1,25-(OH)2D3 inhibited the production of both extracellular and cell-associated immunoreactive IL1
and IL1β. Indomethacin, a prostaglandin synthetase inhibitor, did not alter the inhibitory properties of 1,25-(OH)2D3, suggesting that prostaglandins are not responsible for the inhibitory phenomenon.
We conclude that part of the ability of 1,25-(OH)2D3 to inhibit T cell proliferation may be due to direct effects on monocytes by down-regulating IL-1 production. However, it is unlikely that the immunoregulatory properties of 1,25-(OH)2D3 on T cells are mediated solely through monocytes, and it is possible that the hormone also exerts its influence directly on T cells.
Received August 15, 1988.
This article has been cited by other articles:
![]() |
T. Timonen, S. Nayha, T. Koskela, and E. Pukkala Are sunlight deprivation and influenza epidemics associated with the onset of acute leukemia? Haematologica, November 1, 2007; 92(11): 1553 - 1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Piemonti, P. Monti, M. Sironi, P. Fraticelli, B. E. Leone, E. Dal Cin, P. Allavena, and V. Di Carlo Vitamin D3 Affects Differentiation, Maturation, and Function of Human Monocyte-Derived Dendritic Cells J. Immunol., May 1, 2000; 164(9): 4443 - 4451. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |